Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about mitochondrial_dysfunction: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A mechanism referenced in 1 knowledge graph relationship. Key connections: GCase_deficiency (mechanism) causes.
No AI portrait yet
| Name | mitochondrial_dysfunction |
| Key Genes/Proteins | ALOX15, APOE4, AQP4 |
| Related Diseases | als, alzheimer_disease, alzheimers, Alzheimer's_disease |
| Related Pathways | alpha_synuclein_aggregation, ATP_depletion |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
flowchart TD
N0["mitochondrial_dysfunction"]
N1["ROS"]
N1 -->|"causes"| N0
N2["sirt6"]
N2 -->|"inhibits"| N0
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
class N2 gene| Target | Relation | Type | Str |
|---|---|---|---|
| SPM_synthesis | inhibits | mechanism | 1.00 |
| neurodegeneration | contributes_to | disease | 0.95 |
| alzheimer_disease | involved_in | disease | 0.95 |
| senescent glia | causes | unknown | 0.95 |
| Parkinson's disease | implicated_in | unknown | 0.95 |
| alzheimer_disease | associated_with | disease | 0.95 |
| peripheral neuropathy | implicated_in | unknown | 0.90 |
| brain_aging | involved_in | unknown | 0.90 |
| neuronal_plasticity | associated_with | mechanism | 0.90 |
| cell_damage | contributes_to | unknown | 0.90 |
| neurodegeneration | causes | disease | 0.90 |
| sepsis-associated encephalopathy | contributes_to | unknown | 0.90 |
| oxidative stress | causes | mechanism | 0.90 |
| Ros | associated_with | phenotype | 0.90 |
| ageing | associated_with | unknown | 0.90 |
| alzheimers | implicated_in | disease | 0.90 |
| Alzheimer's_disease | associated_with | disease | 0.90 |
| neurodegeneration | implicated_in | disease | 0.90 |
| als | associated_with | disease | 0.90 |
| alzheimer_disease | contributes_to | disease | 0.90 |
| lipid accumulation | associated_with | unknown | 0.90 |
| ischemia/reperfusion injury | associated_with | unknown | 0.90 |
| Brain Aging | causes | phenotype | 0.90 |
| oxidative stress | contributes_to | mechanism | 0.85 |
| blood-brain barrier integrity | contributes_to | unknown | 0.85 |
| brain_tissue_loss | causes | unknown | 0.85 |
| microglial activation | contributes_to | mechanism | 0.85 |
| Parkinson's disease | contributes_to | unknown | 0.85 |
| neuroinflammation | contributes_to | mechanism | 0.85 |
| DNA damage | causes | mechanism | 0.85 |
| premature_cell_senescence | contributes_to | unknown | 0.85 |
| neuronal death | contributes_to | unknown | 0.85 |
| protein aggregation | associated_with | mechanism | 0.83 |
| mitochondrial DNA release | associated_with | mechanism | 0.82 |
| autophagy | inhibits | pathway | 0.82 |
| inflammatory_signaling | activates | process | 0.80 |
| glaucomatous_neurodegeneration | implicated_in | disease | 0.80 |
| NLRP3 | activates | gene | 0.80 |
| mtDNA | increases | compound | 0.80 |
| ASTROCYTE | causes | cell_type | 0.80 |
| microglial_activation | associated_with | mechanism | 0.80 |
| systemic_toxicity | contributes_to | unknown | 0.80 |
| alpha_synuclein_aggregation | contributes_to | mechanism | 0.80 |
| glioblastoma | contributes_to | unknown | 0.80 |
| neuroinflammation | associated_with | mechanism | 0.80 |
| NAD+_depletion | associated_with | unknown | 0.75 |
| metabolic_syndrome | associated_with | unknown | 0.75 |
| ATP_depletion | causes | mechanism | 0.75 |
| alzheimers | associated_with | disease | 0.75 |
| NAD+ depletion | associated_with | mechanism | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ageing | associated_with | unknown | 0.95 |
| JAK-STAT pathway | causes | unknown | 0.95 |
| ALOX15 | causes | gene | 0.90 |
| beta-amyloid | causes | unknown | 0.90 |
| neuronal ABCA7 deficiency | causes | unknown | 0.90 |
| HK2 | causes | protein | 0.90 |
| mitochondrial_transfer | mediates | mechanism | 0.90 |
| PRKN mutations | causes | gene | 0.90 |
| iron | causes | unknown | 0.90 |
| P2X7 receptor | targets | protein | 0.90 |
| GCase | associated_with | protein | 0.90 |
| ferroptosis | associated_with | mechanism | 0.90 |
| oxidative_stress | associated_with | phenotype | 0.90 |
| alpha_synuclein_aggregation | correlates_with | mechanism | 0.90 |
| iron imbalance | causes | unknown | 0.90 |
| PINK1 mutations | causes | gene | 0.90 |
| iron dyshomeostasis | causes | unknown | 0.90 |
| HIF1A | causes | gene | 0.90 |
| Tau | associated_with | unknown | 0.85 |
| iron overload | contributes_to | unknown | 0.85 |
| GCase | contributes_to | protein | 0.85 |
| oxidative stress | causes | mechanism | 0.85 |
| iron deficiency | contributes_to | unknown | 0.85 |
| GCase | inhibits | protein | 0.85 |
| intracellular_redox_imbalance | contributes_to | unknown | 0.85 |
| mitochondrial_transfer | contributes_to | mechanism | 0.85 |
| TRIP12 | causes | unknown | 0.85 |
| TREM1 | causes | unknown | 0.85 |
| NAD+ depletion | contributes_to | mechanism | 0.85 |
| APOE4 | causes | protein | 0.85 |
| Copper | causes | unknown | 0.85 |
| insulin_resistance | contributes_to | unknown | 0.85 |
| neuroinflammation | contributes_to | mechanism | 0.85 |
| ABCA7 | contributes_to | unknown | 0.85 |
| melatonin | inhibits | drug | 0.85 |
| HSP70 | modulates | protein | 0.85 |
| mitochondrial DNA release | associated_with | mechanism | 0.85 |
| HK2 | involved_in | protein | 0.85 |
| oxidative_stress | modulates | phenotype | 0.85 |
| HDAC | involved_in | unknown | 0.85 |
| oxidative stress | associated_with | mechanism | 0.85 |
| mitochondrial_transfer | associated_with | mechanism | 0.85 |
| aging | causes | unknown | 0.84 |
| APOE4 | modulates | protein | 0.82 |
| GCase | involved_in | protein | 0.80 |
| NNMT | causes | gene | 0.80 |
| calcium_overload | causes | mechanism | 0.80 |
| lipid_droplet_biogenesis | associated_with | pathway | 0.80 |
| mitochondrial_DNA_release | biomarker_for | unknown | 0.80 |
| oxidative damage | associated_with | unknown | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TREM2-Mediated Mitochondrial Dysfunction in Neurodegeneratio | 0.642 | neurodegeneration | Gene expression changes in aging mouse b |
| Mitochondrial Dysfunction Increasing Neuronal Vulnerability | 0.470 | neurodegeneration | How does APOE4 mechanistically increase |
| Mitochondrial Dysfunction in Neurodegeneration | 0.460 | - | - |
| C1q Inhibition Prevents Synaptic Mitochondrial Dysfunction v | 0.455 | neurodegeneration | Why does PRKN-mediated mitophagy, typica |
| Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzh | 0.380 | - | Survival Analysis of AD Patient Cohorts: |
| Hippocampal mitochondrial dysfunction accelerates with age a | 0.374 | alzheimers | Allen Mouse Brain Aging Atlas: cross-age |
| Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 | 0.317 | neurodegeneration | Does RGS6 upregulation or D2 autorecepto |
Scientific analyses that reference this entity
Alzheimer's disease | 2026-04-28 | 7 hypotheses Top: 0.725
neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662
neurodegeneration | 2026-04-27 | 0 hypotheses
neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.878
neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.760
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglect [PMID:40581642] | Sanadgol N, Samadi M, Voelz C, Khalseh R | Cell & bioscience | 2025 | 0 |
| The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in [PMID:35635600] | ["Nakagawa Yutaka", "Yamada Shizuo"] | Cellular and molecular neurobi | 2023 | 0 |
| Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Ne [PMID:34366851] | Jassim AH, Inman DM, Mitchell CH | Frontiers in pharmacology | 2021 | 0 |
| How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial [PMID:25999816] | ["Arr\u00e1zola Macarena S", "Silva-Alva | Frontiers in cellular neurosci | 2015 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.72 · 2026-04-28
closed · Rounds: 4 · Score: 0.76 · 2026-04-28
closed · Rounds: 6 · Score: 0.62 · 2026-04-27
closed · Rounds: 4 · Score: 0.59 · 2026-04-27
closed · Rounds: 4 · Score: 0.33 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 6 · Score: 0.75 · 2026-04-26
closed · Rounds: 4 · Score: 0.84 · 2026-04-25
closed · Rounds: 4 · Score: 0.65 · 2026-04-25
closed · Rounds: 4 · Score: 0.75 · 2026-04-22
Hypotheses and analyses mentioning mitochondrial_dysfunction in their description or question text
Score: 0.374 · alzheimers · 2026-04-23
## Mechanistic Overview Hippocampal mitochondrial dysfunction accelerates with age and drives regional AD vulnerability
Score: 0.317 · neurodegeneration · 2026-04-18
## Mechanistic Overview Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochondrial Dysfunction